Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm To Commence Phase 2 Ross River Virus Clinical Trial

Jul 10, 2017 at 2:49 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment